- Home
- IOVA vs POWW Comparison
IOVA vs POWW Comparison
Compare IOVA & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- POWW
- Stock Information
- Founded
- IOVA 2007
- POWW 1990
- Country
- IOVA United States
- POWW United States
- Employees
- IOVA N/A
- POWW N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- POWW Ordnance And Accessories
- Sector
- IOVA Health Care
- POWW Industrials
- Exchange
- IOVA Nasdaq
- POWW Nasdaq
- Market Cap
- IOVA 1.0B
- POWW 219.7M
- IPO Year
- IOVA N/A
- POWW N/A
- Fundamental
- Price
- IOVA $1.75
- POWW $1.99
- Analyst Decision
- IOVA Strong Buy
- POWW Hold
- Analyst Count
- IOVA 9
- POWW 1
- Target Price
- IOVA $15.50
- POWW $1.50
- AVG Volume (30 Days)
- IOVA 13.9M
- POWW 584.8K
- Earning Date
- IOVA 05-08-2025
- POWW 06-12-2025
- Dividend Yield
- IOVA N/A
- POWW N/A
- EPS Growth
- IOVA N/A
- POWW N/A
- EPS
- IOVA N/A
- POWW N/A
- Revenue
- IOVA $212,679,000.00
- POWW $135,498,023.00
- Revenue This Year
- IOVA $182.20
- POWW $5.67
- Revenue Next Year
- IOVA $62.10
- POWW N/A
- P/E Ratio
- IOVA N/A
- POWW N/A
- Revenue Growth
- IOVA 11070.12
- POWW N/A
- 52 Week Low
- IOVA $2.70
- POWW $0.95
- 52 Week High
- IOVA $13.60
- POWW $2.86
- Technical
- Relative Strength Index (RSI)
- IOVA 23.78
- POWW 67.78
- Support Level
- IOVA $3.02
- POWW $1.93
- Resistance Level
- IOVA $3.31
- POWW $2.05
- Average True Range (ATR)
- IOVA 0.24
- POWW 0.12
- MACD
- IOVA -0.09
- POWW 0.02
- Stochastic Oscillator
- IOVA 4.81
- POWW 75.86
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.